脑小血管病(cerebral small vessel disease, CSVD)多指颅内小血管的多种病变所导致的一系列临床表现的综合征,该病会诱发认知障碍、躯体功能障碍等症状,其作为一项疾病负担,越来越受到医学界的关注。目前,脑小血管病的病因尚不明确,除...脑小血管病(cerebral small vessel disease, CSVD)多指颅内小血管的多种病变所导致的一系列临床表现的综合征,该病会诱发认知障碍、躯体功能障碍等症状,其作为一项疾病负担,越来越受到医学界的关注。目前,脑小血管病的病因尚不明确,除传统的脑血管原因之外,遗传、免疫及炎性反应等相关因素越来越引起学者们的重视,其相关的生物学标志物也逐渐成为学界研究的热点,本文重点就脑小血管病生物学标志物进行综述。展开更多
Multiple myeloma(MM) is a common malignant hematological disease. Dysregulation of micro RNAs(mi RNAs) in MM cells and bone marrow microenviroment has important impacts on the initiation and progression of MM and drug...Multiple myeloma(MM) is a common malignant hematological disease. Dysregulation of micro RNAs(mi RNAs) in MM cells and bone marrow microenviroment has important impacts on the initiation and progression of MM and drug resistance in MM cells. Recently, it was reported that MM patient serum and plasma contained sufficiently stable mi RNA signatures, and circulating mi RNAs could be identified and measured accurately from body fluid. Compared to conventional diagnostic parameters, the circulating mi RNA profile is appropriate for the diagnosis of MM and estimates patient progression and therapeutic outcome with higher specificity and sensitivity. In this review, we mainly focus on the potential of circulating mi RNAs as diagnostic, prognostic, and predictive biomarkers for MM and summarize the general strategies and methodologies for identification and measurement of circulating mi RNAs in various cancers. Furthermore, we discuss the correlation between circulating mi RNAs and the cytogenetic abnormalities and biochemical parameters assessed in multiple myeloma.展开更多
文摘脑小血管病(cerebral small vessel disease, CSVD)多指颅内小血管的多种病变所导致的一系列临床表现的综合征,该病会诱发认知障碍、躯体功能障碍等症状,其作为一项疾病负担,越来越受到医学界的关注。目前,脑小血管病的病因尚不明确,除传统的脑血管原因之外,遗传、免疫及炎性反应等相关因素越来越引起学者们的重视,其相关的生物学标志物也逐渐成为学界研究的热点,本文重点就脑小血管病生物学标志物进行综述。
基金supported by the National Natural Science Foundation of China(8130177481470362)
文摘Multiple myeloma(MM) is a common malignant hematological disease. Dysregulation of micro RNAs(mi RNAs) in MM cells and bone marrow microenviroment has important impacts on the initiation and progression of MM and drug resistance in MM cells. Recently, it was reported that MM patient serum and plasma contained sufficiently stable mi RNA signatures, and circulating mi RNAs could be identified and measured accurately from body fluid. Compared to conventional diagnostic parameters, the circulating mi RNA profile is appropriate for the diagnosis of MM and estimates patient progression and therapeutic outcome with higher specificity and sensitivity. In this review, we mainly focus on the potential of circulating mi RNAs as diagnostic, prognostic, and predictive biomarkers for MM and summarize the general strategies and methodologies for identification and measurement of circulating mi RNAs in various cancers. Furthermore, we discuss the correlation between circulating mi RNAs and the cytogenetic abnormalities and biochemical parameters assessed in multiple myeloma.
